Pruritic papular eruption of HIV - Revision history

Rossdonaldson1: /* Background */

2024-12-11T17:29:10Z

Background

← Older revision		Revision as of 17:29, 11 December 2024
Line 1:		Line 1:
	==Background==		==Background==
			{{Skin anatomy background images}}
	*Most common [[rash]] of [[HIV]]<ref>Cutaneous manifestations of HIV in the era of highly active antiretroviral therapy: an institutional urban clinic experience. Zancanaro PC et al. J Am Acad Dermatol. 2006 Apr;54(4):581-8.</ref>		*Most common [[rash]] of [[HIV]]<ref>Cutaneous manifestations of HIV in the era of highly active antiretroviral therapy: an institutional urban clinic experience. Zancanaro PC et al. J Am Acad Dermatol. 2006 Apr;54(4):581-8.</ref>
	*Presenting symptom of HIV in up to ~80% cases		*Presenting symptom of HIV in up to ~80% cases

Rossdonaldson1: /* Clinical Features */

2020-09-10T17:24:53Z

Clinical Features

← Older revision		Revision as of 17:24, 10 September 2020
Line 9:		Line 9:
	[[File:PMC4808702 gr1.png\|thumb\|Intensely pruritic papular rash with greatest severity on the extensor surfaces of extremities.]]		[[File:PMC4808702 gr1.png\|thumb\|Intensely pruritic papular rash with greatest severity on the extensor surfaces of extremities.]]
	[[File:PMC3195174 IJSTD-32-118-g001.png\|thumb\|Pruritic papular eruptions as presenting illness of HIV.]]		[[File:PMC3195174 IJSTD-32-118-g001.png\|thumb\|Pruritic papular eruptions as presenting illness of HIV.]]
			[[File:PMC3168063 IJSTD-30-79-g002.png\|thumb\|Pruritic papular lesions on hands.]]
	*[[Pruritus\|Pruritic]]		*[[Pruritus\|Pruritic]]
	*Diffusely, symmetrically distributed [[rash]]		*Diffusely, symmetrically distributed [[rash]]

Rossdonaldson1: /* Clinical Features */

2020-09-10T17:23:45Z

Clinical Features

← Older revision		Revision as of 17:23, 10 September 2020
Line 8:		Line 8:
	==Clinical Features==		==Clinical Features==
	[[File:PMC4808702 gr1.png\|thumb\|Intensely pruritic papular rash with greatest severity on the extensor surfaces of extremities.]]		[[File:PMC4808702 gr1.png\|thumb\|Intensely pruritic papular rash with greatest severity on the extensor surfaces of extremities.]]
	[[File:PMC3195174 IJSTD-32-118-g001.png\|thumb\|]]		[[File:PMC3195174 IJSTD-32-118-g001.png\|thumb\|Pruritic papular eruptions as presenting illness of HIV.]]
	*[[Pruritus\|Pruritic]]		*[[Pruritus\|Pruritic]]
	*Diffusely, symmetrically distributed [[rash]]		*Diffusely, symmetrically distributed [[rash]]

Rossdonaldson1: /* Clinical Features */

2020-09-10T17:22:41Z

Clinical Features

← Older revision		Revision as of 17:22, 10 September 2020
Line 8:		Line 8:
	==Clinical Features==		==Clinical Features==
	[[File:PMC4808702 gr1.png\|thumb\|Intensely pruritic papular rash with greatest severity on the extensor surfaces of extremities.]]		[[File:PMC4808702 gr1.png\|thumb\|Intensely pruritic papular rash with greatest severity on the extensor surfaces of extremities.]]
			[[File:PMC3195174 IJSTD-32-118-g001.png\|thumb\|]]
	*[[Pruritus\|Pruritic]]		*[[Pruritus\|Pruritic]]
	*Diffusely, symmetrically distributed [[rash]]		*Diffusely, symmetrically distributed [[rash]]

Rossdonaldson1: /* Clinical Features */

2020-09-10T17:18:45Z

Clinical Features

← Older revision		Revision as of 17:18, 10 September 2020
Line 7:		Line 7:

	==Clinical Features==		==Clinical Features==
			[[File:PMC4808702 gr1.png\|thumb\|Intensely pruritic papular rash with greatest severity on the extensor surfaces of extremities.]]
	*[[Pruritus\|Pruritic]]		*[[Pruritus\|Pruritic]]
	*Diffusely, symmetrically distributed [[rash]]		*Diffusely, symmetrically distributed [[rash]]

ClaireLewis at 01:10, 28 September 2019

2019-09-28T01:10:02Z

← Older revision		Revision as of 01:10, 28 September 2019
Line 1:		Line 1:
	==Background==		==Background==
	*Most common rash of HIV<ref>Cutaneous manifestations of HIV in the era of highly active antiretroviral therapy: an institutional urban clinic experience. Zancanaro PC et al. J Am Acad Dermatol. 2006 Apr;54(4):581-8.</ref>		*Most common [[rash]] of [[HIV]]<ref>Cutaneous manifestations of HIV in the era of highly active antiretroviral therapy: an institutional urban clinic experience. Zancanaro PC et al. J Am Acad Dermatol. 2006 Apr;54(4):581-8.</ref>
	*Presenting symptom of HIV in up to ~80% cases		*Presenting symptom of HIV in up to ~80% cases
	*3x more common when CD4 count < 200		*3x more common when CD4 count < 200
Line 7:		Line 7:

	==Clinical Features==		==Clinical Features==
	*Pruritic		*[[Pruritus\|Pruritic]]
	*Diffusely, symmetrically distributed rash		*Diffusely, symmetrically distributed [[rash]]
	*Discrete red bumps initially		**Discrete red bumps initially
	*Extremities/trunk > face		**Extremities/trunk > face
	*Mucous membrane sparing		**Mucous membrane sparing

	==Differential Diagnosis==		==Differential Diagnosis==
	*[[Folliculitis]]		*[[Folliculitis]]
	*[[Cellulitis]]		*[[Cellulitis]]
	*Fungal infection		*[[Fungal infection]]
	*HSV infection		*[[HSV]] infection
	*HPV warts		*[[HPV]] warts
	*Drug reaction		*[[drug rash\|Drug reaction]]
	*Insect bites		*[[Insect bites]]
	*[[Porphyria]]		*[[Porphyria]]

Line 29:		Line 29:

	==Management==		==Management==
	*Initially topical steroids, emollients, PO antihistamines		*Initially [[topical steroids]], emollients, PO [[antihistamines]]
	*[[Doxepin]] 25 mg QHS later line PO med for those without TCA contraindication<ref>Maurer. Dermatologic Manifestations of HIV Infection. Perspective – Dermatologic Manifestations Volume 13 Issue 5 December 2005/January 2006.</ref>		*[[Doxepin]] 25 mg QHS later line PO med for those without TCA contraindication<ref>Maurer. Dermatologic Manifestations of HIV Infection. Perspective – Dermatologic Manifestations Volume 13 Issue 5 December 2005/January 2006.</ref>
	*UV phototherapy for refractory cases		*UV phototherapy for refractory cases

Kxl328 at 05:52, 6 August 2016

2016-08-06T05:52:32Z

← Older revision		Revision as of 05:52, 6 August 2016
Line 30:		Line 30:
	==Management==		==Management==
	*Initially topical steroids, emollients, PO antihistamines		*Initially topical steroids, emollients, PO antihistamines
			*[[Doxepin]] 25 mg QHS later line PO med for those without TCA contraindication<ref>Maurer. Dermatologic Manifestations of HIV Infection. Perspective – Dermatologic Manifestations Volume 13 Issue 5 December 2005/January 2006.</ref>
	*UV phototherapy for refractory cases		*UV phototherapy for refractory cases

Neil.m.young: Text replacement - "==Diagnosis==" to "==Evaluation=="

2016-07-25T10:55:15Z

Text replacement - "==Diagnosis==" to "==Evaluation=="

← Older revision		Revision as of 10:55, 25 July 2016
Line 25:		Line 25:
	{{HIV associated conditions}}		{{HIV associated conditions}}

	==~~Diagnosis~~==		==Evaluation==
	*Appropriate clinical setting		*Appropriate clinical setting

Rossdonaldson1: Text replacement - "f/u" to "follow up"

2016-07-13T07:10:03Z

Text replacement - "f/u" to "follow up"

← Older revision		Revision as of 07:10, 13 July 2016
Line 33:		Line 33:

	==Disposition==		==Disposition==
	*Outpatient dermatology ~~f/u~~		*Outpatient dermatology follow up
	*Average time for recurrence of skin condition ~8 wks		*Average time for recurrence of skin condition ~8 wks

Neil.m.young: Text replacement - "==Differential==" to "==Differential Diagnosis=="

2016-06-26T18:16:20Z

Text replacement - "==Differential==" to "==Differential Diagnosis=="

← Older revision		Revision as of 18:16, 26 June 2016
Line 13:		Line 13:
	*Mucous membrane sparing		*Mucous membrane sparing

	==Differential==		==Differential Diagnosis==
	*[[Folliculitis]]		*[[Folliculitis]]
	*[[Cellulitis]]		*[[Cellulitis]]

← Older revision		Revision as of 17:24, 10 September 2020
Line 9:		Line 9:
	[[File:PMC4808702 gr1.png\|thumb\|Intensely pruritic papular rash with greatest severity on the extensor surfaces of extremities.]]		[[File:PMC4808702 gr1.png\|thumb\|Intensely pruritic papular rash with greatest severity on the extensor surfaces of extremities.]]
	[[File:PMC3195174 IJSTD-32-118-g001.png\|thumb\|Pruritic papular eruptions as presenting illness of HIV.]]		[[File:PMC3195174 IJSTD-32-118-g001.png\|thumb\|Pruritic papular eruptions as presenting illness of HIV.]]
			[[File:PMC3168063 IJSTD-30-79-g002.png\|thumb\|Pruritic papular lesions on hands.]]
	*[[Pruritus\|Pruritic]]		*[[Pruritus\|Pruritic]]
	*Diffusely, symmetrically distributed [[rash]]		*Diffusely, symmetrically distributed [[rash]]